Why is Remus Pharma. falling/rising?

As of 09-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 827.90, which reflects a decrease of Rs 6.1 or 0.73%. The stock has underperformed significantly, with a 1-week return of -8.50% and a year-to-date decline of -33.70%. Today's performance indicates that the stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Additionally, the stock is close to its 52-week low, being only 1.08% away from Rs 819. The delivery volume has also fallen sharply by 56.41% compared to the 5-day average, indicating a decrease in investor participation, which may contribute to the downward pressure on the stock price.
In the broader market context, the Sensex has shown a positive return of 1.18% over the past week, contrasting sharply with Remus Pharmaceuticals' negative performance. This divergence highlights the stock's struggles relative to the overall market, where it has consistently underperformed against the benchmark. The year-to-date performance of the stock is particularly concerning, with a decline of 33.70% compared to a 5.18% increase in the Sensex, further emphasizing the challenges faced by Remus Pharmaceuticals in attracting investor interest amid a generally positive market environment.